← Insider buys
RCUS

Arcus Biosciences, Inc. · Healthcare

COO Jennifer Jarrett sold $1.7M of Arcus Biosciences, Inc.

Sold$1,678,914
$35.35Price
47,500Shares
−30%Stake

What RCUS did after the filing

Filed Sep 22Copier in Sep 23
The stock from Thu, Sep 23 open, $35.84
−1.3%
S&P 500, same days
+6.2%

Measured over 30 trading days, to the Nov 4 close.

Traded Mon, Sep 20. Filed Wed, Sep 22, 4:32 PM ET, after the close. Returns use the Sep 23 open and the Nov 4 close. Not investment advice.